Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients

Proceedings of the National Academy of Sciences of the United States of America

Volumn 110, Issue 52, 2013, Pages 21083-21088

  Ni, Xiaohui ^a,b   Zhuo, Minglei ^c   Su, Zhe ^a   Duan, Jianchun ^c   Gao, Yan ^a   Wang, Zhijie ^c   Zong, Chenghang ^b,e   Bai, Hua ^c   Chapman, Alec R ^b,d   Zhao, Jun ^c   Xu, Liya ^a   An, Tongtong ^c   Ma, Qi ^a   Wang, Yuyan ^c   Wu, Meina ^c   Sun, Yu ^c   Wang, Shuhang ^c   Li, Zhenxiang ^c   Yang, Xiaodan ^c   Yong, Jun ^b   Su, Xiao Dong ^a   Lu, Youyong ^c   Bai, Fan ^a   Xie, X Sunney ^a,b   Wang, Jie ^c   more..

^a PEKING UNIVERSITY   (China)

^b HARVARD UNIVERSITY   (United States)

^c PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

^d HARVARD UNIVERSITY   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cancer diagnostics; Personalized therapy

Indexed keywords

ARTICLE; CANCER PATIENT; CIRCULATING TUMOR CELL; CLINICAL ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; GENE MUTATION; HUMAN; HUMAN CELL; LUNG CANCER; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84891354380     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1320659110     Document Type: Article

References (42)

1. Vogelstein B, et al. (2013) Cancer genome landscapes. Science 339(6127): 1546-1558.
2. Sethi N, Kang Y (2011) Unravelling the complexity of metastasis - molecular understanding and targeted therapies. Nat Rev Cancer 11(10): 735-748.
3. Lee W, et al. (2010) The mutation spectrum revealed by paired genome sequences from a lung cancer patient. Nature 465(7297): 473-477.
4. Vasioukhin V, et al. (1994) Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia. Br J Haematol 86(4): 774-779.
5. Bai H, et al. (2009) Epidermal growth factor receptor mutations in plasma DNA samples predict tumor response in Chinese patients with stages IIIB to IV non-smallcell lung cancer. J Clin Oncol 27(16): 2653-2659.
6. Forshew T, et al. (2012) Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Sci Transl Med 4(136):136ra68.
7. Dawson SJ, et al. (2013) Analysis of circulating tumor DNA to monitor metastatic breast cancer. N Engl J Med 368(13): 1199-1209.
8. Leary RJ, et al. (2012) Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing. Sci Transl Med 4(162):162ra154.
9. Murtaza M, et al. (2013) Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature 497(7447): 108-112.
10. Maheswaran S, et al. (2008) Detection of mutations in EGFR in circulating lung-cancer cells. N Engl J Med 359(4): 366-377.
11. Cristofanilli M, et al. (2004) Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 351(8): 781-791.
12. Krebs MG, et al. (2011) Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancer. J Clin Oncol 29(12): 1556-1563.
13. Magbanua MJ, et al. (2012) Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer. BMC Cancer 12:78.
14. Zong C, Lu S, Chapman AR, Xie XS (2012) Genome-wide detection of single-nucleotide and copy-number variations of a single human cell. Science 338(6114): 1622-1626.
15. Navin N, et al. (2011) Tumour evolution inferred by single-cell sequencing. Nature 472(7341): 90-94.
16. Xu X, et al. (2012) Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor. Cell 148(5): 886-895.
17. Gerlinger M, et al. (2012) Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N Engl J Med 366(10): 883-892.
18. Forbes SA, et al. (2011) COSMIC: Mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res 39(Database issue): D945-D950.
19. Lynch TJ, et al. (2004) Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. N Engl J Med 350(21): 2129-2139.
20. Sequist LV, et al. (2011) Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. Sci Transl Med 3(75):75ra26.
21. Peifer M, et al. (2012) Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet 44(10): 1104-1110.
22. Sutherland KD, et al. (2011) Cell of origin of small cell lung cancer: Inactivation of Trp53 and Rb1 in distinct cell types of adult mouse lung. Cancer Cell 19(6): 754-764.
23. Iafrate AJ, et al. (2004) Detection of large-scale variation in the human genome. Nat Genet 36(9): 949-951.
24. Sebat J, et al. (2004) Large-scale copy number polymorphism in the human genome. Science 305(5683): 525-528.
25. Weir BA, et al. (2007) Characterizing the cancer genome in lung adenocarcinoma. Nature 450(7171): 893-898.
26. Tang YC, Amon A (2013) Gene copy-number alterations: A cost-benefit analysis. Cell 152(3): 394-405.
27. Futreal PA, et al. (2004) A census of human cancer genes. Nat Rev Cancer 4(3): 177-183.
28. Santos GC, Zielenska M, Prasad M, Squire JA (2007) Chromosome 6p amplification and cancer progression. J Clin Pathol 60(1): 1-7.
29. Tabas-Madrid D, Nogales-Cadenas R, Pascual-Montano A (2012) GeneCodis3: A nonredundant and modular enrichment analysis tool for functional genomics. Nucleic Acids Res 40(Web Server issue):W478-W483.
30. Vermaat JS, et al. (2012) Primary colorectal cancers and their subsequent hepatic metastases are genetically different: Implications for selection of patients for targeted treatment. Clin Cancer Res 18(3): 688-699.
31. Kang Y, Pantel K (2013) Tumor cell dissemination: Emerging biological insights from animal models and cancer patients. Cancer Cell 23(5): 573-581.
32. Gasch C, et al. (2013) Heterogeneity of epidermal growth factor receptor status and mutations of KRAS/PIK3CA in circulating tumor cells of patients with colorectal cancer. Clin Chem 59(1): 252-260.
33. Smyth MJ, Hayakawa Y, Takeda K, Yagita H (2002) New aspects of natural-killer-cell surveillance and therapy of cancer. Nat Rev Cancer 2(11): 850-861.
34. Rohland N, Reich D (2012) Cost-effective, high-throughput DNA sequencing libraries for multiplexed target capture. Genome Res 22(5): 939-946.
35. Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25(14): 1754-1760.
36. Li H, et al. (2009) The sequence alignment/map format and SAMtools. Bioinformatics 25(16): 2078-2079.
37. McKenna A, et al. (2010) The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20(9): 1297-1303.
38. Cingolani P, et al. (2012) A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin) 6(2): 80-92.
39. Beroukhim R, et al. (2007) Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma. Proc Natl Acad Sci USA 104(50): 20007-20012.
40. Storey JD (2002) A direct approach to false discovery rates. J R Stat Soc B 64(3): 479-498.
41. Ward JH (1963) Hierarchical grouping to optimize an objective function. J Am Stat Assoc 58(301): 236-244.
42. McQuitty LL (1966) Similarity analysis by reciprocal pairs for discrete and continuous data. Educ Psychol Meas 26: 825-831.